References
- Bell C. Surgical Observations. Longman, Herst, Rees, and Orme, London 1816–1818; Vol I
- Bryant T. Disease of the Breast. Cassell, London 1887
- Denoix P. Treatment of malignant breast cancer. Recent Results in Cancer Research. Springer/Verlag, Berlin 1970; Vol. 31: 92–94
- Mourali N., Tabbane F., Vogt Hoerner G., et al. Choice of treatment according to the rate of growth. Surgery, Radiotherapy and Chemotherapy of Cancer. Excerpta Medica Int Congr Series No. 353, Excerpta Medica, Amsterdam 1975; Vol. V: 11–16
- Tabbane F., Muenz L., Jaziri M., et al. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer 1977; 40: 376–383
- Mourali N., Tabbane F., Jaziri M., . Fulminating breast cancer. Prevention and Detection of Cancer, Part I, H. E. Nieburgs, et al. Marcel Dekker, New York 1977; Vol 1: 545–554
- Costa J., Webber B. L., Levine P. H., et al. Histopathological features of a rapidly progressing breast carcinoma in Tunisia: a study of 94 cases. Int J Cancer 1982; 30: 35–37
- Levine P. H., Tabbane F., Muenz L. R., et al. Hormone receptors in rapidly progressing breast cancer. Cancer 1984; 54: 3012–3016
- Mourali N., Tabbane F., Muenz L. R., et al. Preliminary results of primary systematic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer. Br J Cancer 1982; 45: 367–373
- Bonadonna G., Rossi A., Valagussa P., et al. CMF program for operable breast cancer with positive axillary nodes: Updated analysis on disease-free interval, site of relapse and drug tolerance. Cancer 1977; 39: 2904–2915
- Peto R., Pike M. C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612
- Peto R., Pike M. C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39
- Lee E. L. Statistical Methods for Survival Data Analysis. Wadsworth, Belmont, CA 1980; 298–337
- Cox D. R., Hinkley D. V. Theoretical Statistics. Wiley, New York 1974; 315
- Cox D. R. Regression models and life tables. J R Stat Soc, Series B 1972; 34: 187–220
- Buzdar A. U., Montague E. D., Barker J. L., et al. Management of inflammatory carcinoma of breast with combined modality approach—An update. Cancer 1981; 47: 2537–2542
- Camp E. Inflammatory carcinoma of the breast. The case for conservatism. Am J Surg 1976; 131: 583–586
- Wang C. C. Management of inflammatory carcinoma of the breast. Int J Radial Oncol Biol Phys 1978; 4: 709–710
- Zylberberg B., Salat-Baroux J., Ravina J. H., et al. Initial chemoimmunotherapy in inflammatory carcinoma of the breast. Cancer 1982; 49: 1537–1543
- Schäfer P., Alberto P., Forni M., et al. Surgery as part of a combined modality approach for inflammatory breast carcinoma. Cancer 1987; 59: 1063–1067
- Kramer A., Buzdar A. U. Inflammatory breast carcinoma. Am J Clin Oncol 1986; 9: 541–543
- Rouëssé J., Friedman S., Sarrazin D., et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 1986; 4: 1765–1771
- Hortobagyi N., Buzdar A. U. Progress of inflammatory breast cancer: Cause for cautious optimism. J Clin Oncol 1986; 4: 1727–1729